[Tic disorders].
Hebebrand
Johannes
J
Rothenberger
Aribert
A
D000293:Adolescent; D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D051381:Rats; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use; D013981:Tic Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy; D005879:Tourette Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy
D018726:Anti-Dyskinesia Agents; D000697:Central Nervous System Stimulants; D013976:Tiapamil Hydrochloride
Tic-Störungen.